Literature DB >> 19446302

[Venous thromboembolism risk and antithrombotic prophylaxis among patients admitted to Spanish hospitals (ENDORSE study)].

José Antonio Nieto Rodríguez1.   

Abstract

BACKGROUND AND OBJECTIVES: The proportion of patients at risk of venous thromboembolism (VTE) in Spanish hospitals and, among those, the proportion who receive prophylaxis are not well known. The objective of this study was to obtain this information by means of the analysis of data from the Spanish centres that participated in the international ENDORSE study.
METHODS: Cross-sectional study in 20 Spanish hospitals. VTE risk factors and VTE prophylaxis were assessed in all hospital inpatients, aged 18 years or over, admitted to a surgical ward, and 40 years or over admitted to a medical ward. The 7th Conference of the American College of Chest Physicians (ACCP) guidelines and recommendations were used as a reference to assess risk categories and the prophylaxis given to patients.
RESULTS: 6.554 hospital beds were assessed, and 3.809 inpatients were enrolled; 2.069 (67,5%) were medical and 996 (32,5%) surgical. Based on the ACCP criteria, 1.878 (61,3%) were at risk for VTE, 1.140 (55,1%) were medical and 738 (74,1%) were surgical. According to the ACCP guidelines and recommendations, 731 medical patients at risk of VTE (64,1%, 95% CI 61,3%-66,9%) received appropriate prophylaxis, as compared to 605 (82%; 95% CI 79,2%-84,8%) surgical patients (p<0,001).
CONCLUSIONS: VTE prophylaxis in the Spanish centres was more common in surgical patients than in medical patients. Nevertheless, it is still necessary to extend the VTE prophylaxis to a significant number of patients (29%) at high risk of VTE, particularly in medical wards.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446302     DOI: 10.1016/j.medcli.2009.01.040

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  6 in total

1.  Venous thromboembolism in COPD hospitalized patients.

Authors:  Raquel Barba; Antonio Zapatero; Javier Marco; Juan E Losa; Susana Plaza; Jose Manuel Casas; Jesús Canora
Journal:  J Thromb Thrombolysis       Date:  2012-01       Impact factor: 2.300

2.  Safety of percutaneous nephrolithotomy in patients on chronic anticoagulant or antiplatelet therapy.

Authors:  C Fernández-Baltar; D Pérez-Fentes; J F Sánchez-García; C García-Freire
Journal:  Urolithiasis       Date:  2018-01-22       Impact factor: 3.436

3.  Risk profile, management, and outcomes of patients with venous thromboembolism attended in Spanish Emergency Departments: The ESPHERIA registry.

Authors:  Sonia Jimenez; Pedro Ruiz-Artacho; Marta Merlo; Coral Suero; Albert Antolin; José Ramón Casal; Marta Sanchez; Alejandra Ortega-Duarte; Mar Genis; Pascual Piñera
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

4.  Venous thromboembolism risk & prophylaxis in the acute hospital care setting (ENDORSE), a multinational cross-sectional study: results from the Indian subset data.

Authors:  Ramakrishna Pinjala
Journal:  Indian J Med Res       Date:  2012-07       Impact factor: 2.375

5.  Prevalence of venous thromboembolism risk factors and prophylactic adequacy among general surgical patients in a tertiary care hospital.

Authors:  Abin Chandrakumar; A M Muhammed Sajid; T N K Suriyaprakash; K K Ajmal
Journal:  Indian Heart J       Date:  2016-01-12

6.  Compliance with current VTE prophylaxis guidelines and risk factors linked to complications of VTE prophylaxis in medical inpatients: a prospective cohort study in a Spanish internal medicine department.

Authors:  Ignacio Novo-Veleiro; Lucía Alvela-Suárez; Alba Costa-Grille; Javier Suárez-Dono; Fernando Ferrón-Vidan; Antonio Pose-Reino
Journal:  BMJ Open       Date:  2018-05-14       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.